Monique Melis
About Monique Melis
Monique Melis is the MSL Manager of Innovative Medicines at Bristol Myers Squibb, with extensive experience in oncology and hematology.
Current Role at Bristol Myers Squibb
Monique Melis is currently working at Bristol Myers Squibb as an MSL Manager Innovative Medicines. Her role involves managing medical science liaisons and overseeing the development and implementation of innovative therapeutic medicines. With extensive experience in oncology and hematology, she brings a diverse skill set and knowledge base to the position.
Previous Roles at Bristol Myers Squibb
Monique Melis has held multiple roles at Bristol Myers Squibb over more than 7 years. From 2017 to 2020, she was a Medical Science Manager Oncology in Utrecht en omgeving, Nederland. Prior to that, she served as a Scientific Advisor Hematology, from 2016 to 2017 for 10 months, also in Utrecht en omgeving, Nederland. These roles have equipped her with a thorough understanding of both oncology and hematology therapeutic areas.
Academic and Industry Experience
Monique Melis has a well-rounded background in both academic and industry settings. She transitioned from being a postdoctoral research associate at the University of Manchester, where she worked for 6 months in 2011, to a postdoctoral fellow at Antoni van Leeuwenhoek from 2012 to 2016 in the Amsterdam Area, Netherlands. This combination of experiences has provided her with a robust foundation in cancer studies and research methodologies.
Educational Background
Monique Melis has a comprehensive educational history spanning three distinguished institutions. She earned her PhD in Cancer Studies from The University of Manchester from 2007 to 2011. Before that, she completed her MSc in Cancer Genomics and Developmental Biology at Universiteit Utrecht from 2004 to 2007. Her academic journey began with a BSc in Life Sciences, Zoology, Faculty Nature and Techniques from Hogeschool van Utrecht, achieved between 2000 and 2004.
Expertise in Cancer Genomics and Developmental Biology
Specializing in cancer genomics and developmental biology, Monique Melis has developed a substantial expertise that is highly relevant to her current role in innovative medicines. Her background includes extensive research and practical application in these fields, making her a valuable asset in the development of new cancer therapies.